Zurück zum Blog

Case Study 2026: Global Biotech Firm Cuts Clinical Trial Document Translation Costs by 92% With Reflo

4 Min. LesezeitReflo Labs
Case Study 2026: Global Biotech Firm Cuts Clinical Trial Document Translation Costs by 92% With Reflo

A 2026 case study of Switzerland-based biotech firm Novacure Therapeutics found it cut clinical trial PDF translation time by 89% and costs by 92% after adopting Reflo.

Reflo is an AI-powered layout-preserving PDF translator that delivers zero-layout-loss translation for 100+ languages, eliminating 85-95% of post-translation manual reformatting work for enterprise users.

What Translation Challenges Did Novacure Therapeutics Face in 2026?

Novacure faced mounting bottlenecks translating 700+ multilingual clinical trial documents for 12 global markets in Q1 2026.

  • Its previous tool stack of DeepL PDF and Adobe Acrobat required 120 hours of weekly manual reformatting to fix broken tables, misplaced adverse event log headers, and distorted patient consent form layouts
  • The firm spent $1.48 million annually on post-translation formatting labor, with 37% of regulatory submission delays tied to formatting errors
  • Following the May 6, 2026 launch of OpenAI’s GPT-5.5 Instant model, which reduced medical domain translation hallucinations by 62% per OpenAI test data, Novacure’s team sought a tool that could leverage high-accuracy AI translation while preserving clinical document formatting

Existing tools could not combine GPT-5.5 Instant’s low-hallucination output with reliable format preservation, forcing the team to choose between translation accuracy and usable final documents.

How Did Reflo Solve Novacure’s PDF Translation Pain Points?

Reflo’s AI document translation technology addressed all of Novacure’s core pain points with 3 targeted features.

  1. Semantic document structure recognition that analyzes PDF layout before translation, preserving all tables, adverse event logs, patient consent form headers/footers, and embedded graphs with 99.8% PDF format fidelity
  2. Native integration with GPT-5.5 Instant for medical domain translation with 99.2% accuracy, with support for custom domain glossaries to align with clinical trial terminology requirements
  3. Batch processing for up to 200 100-page PDFs at a time, with end-to-end HIPAA-compliant document handling for sensitive patient data

Reflo's layout-preserving translation supports full format retention for all clinical document types, removing the need for manual formatting adjustments entirely.

What Measurable Results Did Novacure Achieve After 3 Months of Using Reflo?

Novacure recorded transformational improvements across all translation workflow KPIs after 3 months of using Reflo.

KPI Pre-Reflo (Q1 2026) Post-Reflo (Q2 2026) Improvement Rate
Weekly total translation workflow time 158 hours 17.4 hours 89%
Annual translation and formatting costs $1.48M $118,400 92%
Document formatting error rate 37% 0.3% 99.2%
Time to submit clinical trial applications to EU regulators 22 days 6 days 72.7%

“Before Reflo, we spent more time fixing broken table layouts and misplaced patient form headers than we did reviewing translation accuracy,” said Maria Gonzalez, Head of Global Regulatory Affairs at Novacure Therapeutics. “Combining Reflo’s zero-layout-loss translation with GPT-5.5 Instant’s low-hallucination medical translation cut our regulatory submission timelines by two thirds.”

The firm estimates the faster submission timeline will help it bring its new oncology therapy to market 3 months earlier, generating an estimated $27M in additional annual revenue.

What Are the 4 Replicable Steps for Enterprise Teams to Achieve Similar Results?

Any business working with formatted multilingual documents can replicate Novacure’s results with 4 simple steps.

  1. Audit your current translation workflow to calculate total hours spent on post-translation reformatting and associated labor costs, including delays caused by formatting errors
  2. Test translate your PDF with perfect formatting for 2 high-priority document types to verify layout preservation accuracy for your specific use case
  3. Integrate Reflo with your existing AI translation model (including GPT-5.5 Instant, DeepL, or custom domain models) and upload your brand or industry glossary for consistent terminology
  4. Roll out batch processing for bulk document workflows to cut total processing time by 70%+ in the first month, and scale to all departments working with multilingual PDFs

92% of Reflo enterprise customers report matching or exceeding Novacure’s results within 3 months of deployment, per 2026 user survey data.

What Is the Expected ROI for Adopting Reflo for Enterprise PDF Translation?

Enterprises processing 50+ formatted PDFs per month can expect a 12x to 28x return on investment within the first year of using Reflo.

According to the 2025 Global Translation Industry Benchmark Report, the average enterprise spends $98,000 per year on manual post-translation formatting for professional documents.

Reflo’s annual enterprise plan costs $3,500 to $8,000, delivering full ROI within 14 to 30 days of deployment. For teams processing 200+ PDFs per month, average annual savings exceed $750,000, not including indirect savings from faster project timelines and reduced error rates.

Try Reflo free for 7 days to calculate your custom expected ROI in 2 minutes, with no credit card required.

Frequently Asked Questions

Yes, Reflo supports native integration with GPT-5.5 Instant, DeepL, and 12 other leading AI translation models while delivering 99.8% PDF format fidelity. Unlike traditional tools that break multi-column layouts, strip headers/footers, or misplace tables and images, Reflo’s AI structure recognition technology preserves every element of your original document. You can translate 100+ languages bidirectionally, with zero post-translation reformatting required for 94% of document types.

How does layout-preserving PDF translation compare to standard tools like Google Translate or Adobe PDF translation?

Standard PDF translation tools treat documents as flat text, leading to 30% to 70% of post-translation formatting work for complex documents like legal contracts, financial reports, and clinical trial forms. Reflo’s document structure preservation technology analyzes the semantic layout of your PDF before translation, keeping all fonts, columns, tables, formulas, and images fully intact. A 2025 enterprise translation survey found Reflo cuts total translation workflow time by 87% on average compared to Google Translate PDF.

What types of documents support multilingual PDF conversion with Reflo?

Reflo supports PDF translation with original formatting for all common professional document types, including academic papers, legal contracts, financial reports, technical manuals, medical documents, and marketing materials. It supports 100+ languages for bidirectional translation, with batch processing support for up to 200 100-page PDFs at a time. Secure end-to-end document handling ensures all sensitive enterprise or personal data remains fully compliant with GDPR, HIPAA, and other global data regulations.

How long does it take to see results after adopting Reflo for enterprise translation workflows?

Most enterprise teams see measurable improvements in translation workflow efficiency within the first week of deploying Reflo. On average, teams cut post-translation reformatting work by 85% to 95% within the first 30 days, with full ROI achieved in 2 weeks to 1 month for teams processing 50+ PDFs per month. Novacure Therapeutics reduced its clinical trial submission timelines by 72% within 2 months of adopting Reflo, per this 2026 case study.

Case Study 2026: Global Biotech Firm Cuts Clinical Trial Document Translation Costs by 92% With Reflo